Insmed (INSM) PT Raised to $40 at BofA Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $95.06 +1.08%
Rating Summary:
31 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Rating Summary:
31 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Join SI Premium – FREE
BofA Securities analyst Jason Zemansky raised the price target on Insmed (NASDAQ: INSM) to $40.00 (from $37.00) while maintaining a Buy rating.
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $213 at Morgan Stanley
- Six Flags Entertainment (FUN) PT Lowered to $14 at Citizens - 'One of the Worst-Performing' Consumer Stocks
- Crown Castle (CCI) PT Lowered to $91 at BMO Capital Following Mixed Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
